Li, Qiao http://orcid.org/0000-0002-4547-1266
Liu, Jiaxuan
Zhang, Qingyuan
Ouyang, Quchang
Zhang, Yang
Liu, Qiang http://orcid.org/0000-0002-5451-4862
Sun, Tao
Ye, Feng http://orcid.org/0000-0002-9159-7767
Zhang, Baochun
Xia, Summer
Zhang, Bangyong
Xu, Binghe
Funding for this research was provided by:
Chinese Academy of Medical Sciences (CIFMS 2021-I2M-1-014, CIFMS 2022-I2M-2-002)
CAMS | Cancer Institute and Hospital, Chinese Academy of Medical Sciences (CICAMS-MOTRP2022004)
Article History
Received: 8 July 2023
Accepted: 17 January 2024
First Online: 3 February 2024
Competing interests
: B.X. reports receiving advisory fees from Novartis and AstraZeneca and fees for serving on a speakers’ bureau from Pfizer and Roche. The remaining authors declare no competing interests.